# Healthplus.ai

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/healthplus-ai

- Industry: Software
- Headquarters: Amsterdam, Netherlands
- Website: www.healthplus.ai/
- Total disclosed funding: $2.7M
- Latest round: Seed (Nov 7, 2025)
- Investors on record: 3

## About

Healthplus.ai, based in the Netherlands, specializes in proactive surgical care by utilizing advanced artificial intelligence to enhance clinical decision-making and reduce postoperative infection risks.Founded in 2017 and headquartered in Amsterdam, Netherlands, Healthplus.ai develops AI-driven solutions for surgical care. The company specializes in the PERISCOPE ® tool, which integrates with electronic health records (EHR) to improve patient monitoring. In November 2025, Healthplus.ai successfully raised EUR 2.3 million in Seed funding from investors including LUMO Labs BV and Pathena, bringing their total raised to EUR 2.3 million.Healthplus.ai specializes in proactive surgical care through its core product, the PERISCOPE ® clinical-decision-support tool. This EHR-integrated solution harnesses advanced artificial intelligence to analyze existing patient data, facilitating the early identification of individuals at high, medium, or low risk of postoperative infections, such as pneumonia or wound infections. By providing real-time infection predictions through a user-friendly dashboard integrated into healthcare workflows, PERISCOPE ® reduces the burden on medical staff, enhances patient monitoring, and aims to decrease readmissions and the economic impact of infections. The company targets healthcare providers and hospitals across various geographical markets, including Europe and North America, seeking to improve surgical outcomes for over 50 million patients annually by 2029.Healthplus.ai generates revenue through partnerships and subscriptions with healthcare institutions that adopt its PERISCOPE ® system. Hospitals and clinics pay for access to the software via a subscription model, often with tiered pricing based on institutional size and implementation scale. The PERISCOPE ® product is essential for enhancing patient care and operational efficiency, reflected in the value it provides to healthcare providers. Clients benefit from continuous software updates and support, ensuring that the predictive capabilities of PERISCOPE ® remain aligned with their specific patient populations and clinical protocols.In November 2025, Healthplus.ai raised EUR 2.3 million in Seed funding, led by Elevating Capital, to support its growth strategy. The company aims to expand its presence in Europe and the US by securing FDA clearance, integrating with major EHR systems, and enhancing its AI risk models for broader perioperative coverage. This strategic investment will help Healthplus.ai to accelerate its market entry and improve its product offerings.

## Funding rounds

- Seed, Nov 7, 2025, $2.7M — Pathena, LUMO Labs BV, ROM InWest

## Investors

- Pathena (https://capitalatlas.ai/funds/pathena) — Seed
- LUMO Labs BV (https://capitalatlas.ai/funds/lumo-labs-bv) — Seed
- ROM InWest (https://capitalatlas.ai/funds/rom-inwest) — Seed